{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:29:56Z","timestamp":1789594196732,"version":"build-2803163510"},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1628,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1111\/j.1600-0609.2011.01582.x","type":"journal-article","created":{"date-parts":[[2011,2,2]],"date-time":"2011-02-02T17:32:34Z","timestamp":1296667954000},"page":"332-338","source":"Crossref","is-referenced-by-count":61,"title":["Survival in a large cohort of Greek patients with transfusion-dependent beta thalassaemia and mortality ratios compared to the general population"],"prefix":"10.1111","volume":"86","author":[{"given":"Vassilis","family":"Ladis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgos","family":"Chouliaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios","family":"Berdoukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Chatziliami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Fragodimitri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotis","family":"Karabatsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis","family":"Kattamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markissia","family":"Karagiorga-Lagana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,18]]},"reference":[{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1196\/annals.1345.067","article-title":"Longitudinal study of survival and causes of death in patients with thalassemia major in Greece","volume":"1054","author":"Ladis","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-10-42","article-title":"Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance","volume":"10","author":"Modell","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB3|cit3","first-page":"1187","article-title":"Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004","volume":"91","author":"Telfer","year":"2006","journal-title":"Haematologica"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2005-07-2933","article-title":"Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major","volume":"107","author":"Borgna-Pignatti","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bcmd.2009.01.002","article-title":"Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies","volume":"42","author":"Maggio","year":"2009","journal-title":"Blood Cells Mol Dis"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1600-0609.2010.01491.x","article-title":"Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit","volume":"85","author":"Ladis","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"22","author":"Anderson","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/02841850903292743","article-title":"Magnetic resonance imaging signal reduction may precede volume loss in the pituitary gland of transfusion-dependent beta-thalassemic patients","volume":"51","author":"Hekmatnia","year":"2010","journal-title":"Acta Radiol"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2009-06-225615","article-title":"Pancreatic iron loading predicts cardiac iron loading in thalassemia major","volume":"114","author":"Noetzli","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00277-009-0701-2","article-title":"Organ-specific hemosiderosis and functional correlation in Chinese patients with thalassemia intermedia and hemoglobin H disease","volume":"88","author":"Au","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00330-006-0507-8","article-title":"The pancreas in beta-thalassemia major: MR imaging features and correlation with iron stores and glucose disturbances","volume":"17","author":"Papakonstantinou","year":"2007","journal-title":"Eur Radiol"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB12|cit12","volume-title":"Statistical Models in Epidemiology","author":"David Clayton","year":"1998"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1600-0609.2009.01218.x","article-title":"Cardiac related death in thalassaemia major: time trend and risk factors in a large Greek Unit","volume":"82","author":"Chouliaras","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(89)90264-X","article-title":"Survival and causes of death in thalassaemia major","volume":"2","author":"Zurlo","year":"1989","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/bmj.284.6322.1081","article-title":"Survival and desferrioxamine in thalassaemia major","volume":"284","author":"Modell","year":"1982","journal-title":"Br Med J (Clin Res Ed)."},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bcmd.2010.05.005","article-title":"Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone","volume":"45","author":"Lai","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(00)02357-6","article-title":"Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register","volume":"355","author":"Modell","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB18|cit18","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna-Pignatti","year":"2004","journal-title":"Haematologica"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-0609.2004.00335.x","article-title":"Reversal of heart failure in thalassemia major by combined chelation therapy: a case report","volume":"74","author":"Tsironi","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2141.2009.07970.x","article-title":"Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major","volume":"148","author":"Farmaki","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00277-003-0820-0","article-title":"Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with beta-thalassemia major","volume":"83","author":"Wu","year":"2004","journal-title":"Ann Hematol"},{"issue":"Suppl","key":"10.1111\/j.1600-0609.2011.01582.x-BIB22|cit22","first-page":"ECR19","article-title":"Successful recovery of acute hemosiderotic heart failure in beta-thalassemia major treated with a combined regimen of desferrioxamine and deferiprone","volume":"6","author":"Tavecchia","year":"2006","journal-title":"Haematologica"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1532-429X-11-20","article-title":"The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study","volume":"11","author":"Berdoukas","year":"2009","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05202.x","article-title":"Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance","volume":"127","author":"Anderson","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","article-title":"A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance","volume":"115","author":"Tanner","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3324\/haematol.12352","article-title":"Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia","volume":"93","author":"Harmatz","year":"2008","journal-title":"Haematologica"},{"key":"10.1111\/j.1600-0609.2011.01582.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ajh.21398","article-title":"The influence of treatment in specialized centers on survival of patients with thalassemia major","volume":"84","author":"Forni","year":"2009","journal-title":"Am J Hematol"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2011.01582.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0609.2011.01582.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T05:24:33Z","timestamp":1625635473000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2011.01582.x"}},"subtitle":["Survival in transfusion-dependent beta thalassaemia"],"short-title":[],"issued":{"date-parts":[[2011,3,18]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01582.x","relation":{},"ISSN":["0902-4441"],"issn-type":[{"value":"0902-4441","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,18]]}}}